These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
75 related items for PubMed ID: 17230059
1. Growth impairment in beta-thalassemia major: the role of trace element deficiency and other potential factors. Eshghi P, Alavi S, Ghavami S, Rashidi A. J Pediatr Hematol Oncol; 2007 Jan; 29(1):5-8. PubMed ID: 17230059 [Abstract] [Full Text] [Related]
2. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, Zilber R, Yaniv I, Tamary H. Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898 [Abstract] [Full Text] [Related]
3. [Study on the distribution and correlation of trace elements in whole blood of children in Beijing]. Song WQ, Xu XW, Li QL, Cai YY. Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):564-8. PubMed ID: 19040038 [Abstract] [Full Text] [Related]
4. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency. Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M. J Pediatr Endocrinol Metab; 1998 Jun; 11 Suppl 3():845-9. PubMed ID: 10091155 [Abstract] [Full Text] [Related]
5. Zinc status in patients with major beta-thalassemia. Mehdizadeh M, Zamani G, Tabatabaee S. Pediatr Hematol Oncol; 2008 Jun; 25(1):49-54. PubMed ID: 18231954 [Abstract] [Full Text] [Related]
7. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia. Hamidah A, Arini MI, Zarina AL, Zulkifli SZ, Jamal R. Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):900-5. PubMed ID: 19058587 [Abstract] [Full Text] [Related]
8. Malnutrition and growth abnormalities in children with beta thalassemia major. Tienboon P, Sanguansermsri T, Fuchs GJ. Southeast Asian J Trop Med Public Health; 1996 Jun; 27(2):356-61. PubMed ID: 9280002 [Abstract] [Full Text] [Related]
9. [Relationship between growth disorders and iron overload in children with beta-thalassemia major]. Huang YL, Liu S, Xia T, Hao WG, Liang W, Sun X. Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):603-6. PubMed ID: 18947480 [Abstract] [Full Text] [Related]
10. Growth and sexual maturation in children with thalassemia major. Yesilipek MA, Bircan I, Oygür N, Ertug H, Yegin O, Güven AG. Haematologica; 1993 Oct; 78(1):30-3. PubMed ID: 8491419 [Abstract] [Full Text] [Related]
11. Stiffness of the abdominal aorta in beta-thalassemia major patients related with body iron load. Ulger Z, Aydinok Y, Gurses D, Levent E, Ozyurek AR. J Pediatr Hematol Oncol; 2006 Oct; 28(10):647-52. PubMed ID: 17023824 [Abstract] [Full Text] [Related]
12. Zinc Status in Beta Thalassemia Major Patients. Karunaratna AMDS, Ranasingha JGS, Mudiyanse RM. Biol Trace Elem Res; 2018 Jul; 184(1):1-6. PubMed ID: 28940159 [Abstract] [Full Text] [Related]
13. Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy. El-Beshlawy A, Youssry I, El-Saidi S, El Accaoui R, Mansi Y, Makhlouf A, Taher A. Pediatr Hematol Oncol; 2008 Dec; 25(8):734-43. PubMed ID: 19065439 [Abstract] [Full Text] [Related]
14. Assessment of thyroid functions and its role in body growth in thalassemia major. Jain M, Sinha RS, Chellani H, Anand NK. Indian Pediatr; 1995 Feb; 32(2):213-9. PubMed ID: 8635784 [Abstract] [Full Text] [Related]
15. [Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major]. Rodríguez Galindo C, Ortega Aramburu JJ, Alonso JL, Albisu M, Casaldáliga J, Díaz de Heredia C, Olivé T, Bastida P. Med Clin (Barc); 1994 May 21; 102(19):721-4. PubMed ID: 8041200 [Abstract] [Full Text] [Related]
16. Investigation of the distribution of lymphocyte subsets and zinc levels in multitransfused beta-thalassemia major patients. Al-Awadhi AM, Alfadhli SM, Al-Khaldi D, Borhama M, Borusly M. Int J Lab Hematol; 2010 Apr 21; 32(2):191-6. PubMed ID: 19453575 [Abstract] [Full Text] [Related]
17. [Growth and endocrine function in major thalassemia]. Pérignon F, Brauner R, Souberbielle JC, de Montalembert M, Girot R. Arch Fr Pediatr; 1993 Oct 21; 50(8):657-63. PubMed ID: 8002739 [Abstract] [Full Text] [Related]
18. Survival in medically treated patients with homozygous beta-thalassemia. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR. N Engl J Med; 1994 Sep 01; 331(9):574-8. PubMed ID: 8047081 [Abstract] [Full Text] [Related]
19. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India. Italia KY, Jijina FJ, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB. Clin Chim Acta; 2009 Sep 01; 407(1-2):10-5. PubMed ID: 19545554 [Abstract] [Full Text] [Related]
20. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens. Viprakasit V, Tanphaichitr VS, Mahasandana C, Assteerawatt A, Suwantol L, Veerakul G, Kankirawatana S, Pung-Amritt P, Suvatte V. J Med Assoc Thai; 2001 Jul 01; 84(7):929-41. PubMed ID: 11759973 [Abstract] [Full Text] [Related] Page: [Next] [New Search]